Arcus Biosciences, Inc. , a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for people with cancer, today announced the ...
Reform UK’s fag-in-mouth, pint-in-hand public image belies a determined effort to professionalise the insurgent party to ...
Wells Fargo analyst Mike Mayo raised the firm’s price target on Goldman Sachs (GS) to $720 from $680 and keeps an Overweight rating on the ...
BofA raised the firm’s price target on Goldman Sachs (GS) to $750 from $675 and keeps a Buy rating on the shares. The firm’s takeaway based on ...
Goldman Sachs has appointed insiders William Connolly and Michael Voris as co-heads of Equity Capital Markets (ECM) in the ...
Goldman Sachs has ended a ban on underwriting companies with all-White, all-male boards, becoming the latest corporate giant ...
Goldman Sachs on Monday raised its year-end 2025 gold price forecast to $3,100 per ounce, up from $2,890, citing sustained ...
Goldman Sachs Group Inc. has changed its stance on underwriting initial public offerings (IPOs) for companies with all-white ...
Shares of Goldman Sachs Group Inc. GS rallied 1.79% to $660.55 Friday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index SPX falling 0.01% to ...
After years of bashing cryptocurrencies, US investment bank Goldman Sachs has admitted it was wrong about the asset class. Not in words, but with actions. The investment giant, which manages ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...